Benzinga  Jun 17  Comment 
Medivation (NASDAQ: MDVN) and Astellas announced today that the first patients have been enrolled in TRUMPET (Treatment Registry for Outcomes in CRPC Patients), a prospective observational patient registry designed to better understand the unique...
Benzinga  Apr 20  Comment 
In a report published Monday, analysts at Credit Suisse initiated coverage of Medivation Inc (NASDAQ: MDVN) with a Neutral rating and a price target of $115. The analysts believe that the company's current valuation is driven by the M&A...
Benzinga  Mar 25  Comment 
In a report published Wednesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Medivation, Inc. (NASDAQ: MDVN), and raised the price target from $125.00 to $142.00. In the report, Brean Capital noted, "At the European...
Motley Fool  Mar 22  Comment 
You've got to start somewhere. Here's our top picks of biotechs with just one drug on the market.
Benzinga  Mar 11  Comment 
In a report published Wednesday, Wedbush Securities analyst David M. Nierengarten reiterated an Outperform rating on Medivation Inc. (NASDAQ: MDVN), and raised the price target from $118.00 to $138.00. In the report, Wedbush Securities noted,...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki